Methylation profiling

Dataset Information

0

Opioid receptor signaling suppresses leukemia by inducing TET-dependent DNA demethylation


ABSTRACT: Acute myeloid leukemia (AML) is a type of heterogeneous and fatal hematopoietic malignancy. The ten-eleven translocation (TET) mediated DNA demethylation is known to be critically associated with AML pathogenesis. Through chemical compound screening, we found that the opioid receptor agonist, loperamide hydrochloride (OPA1), significantly suppresses AML cell viability. The potential therapeutic effects of opioid receptor agonists, especially OPA1, were then verified in AML cells in vitro, and t(11q23) and t(8;21) AML mouse models in vivo. OPA1-induced activation of OPRM1 enhanced the transcription of TET2, increased DNA 5-hydroxymethylcytosine (5hmC) modification, and in turn, activated NFκB signaling. Notably, AML with TET2 mutations or chemotherapy resistance were highly sensitive to OPA1. Our results reveal a previously unknown OPRM1-TET2-5hmC-TRAF2 regulatory axis in AML, and suggest that opioid agonists, particularly OPA1, an FDA-approved antidiarrheal drug, have therapeutic potential in AML, especially in TET2 mutated and chemotherapy-resistant AML, which have a poor prognosis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE165803 | GEO | 2024/01/19

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-03-20 | GSE147510 | GEO
2023-03-20 | GSE147509 | GEO
2024-01-19 | GSE165650 | GEO
| PRJNA615085 | ENA
2015-04-22 | E-GEOD-59579 | biostudies-arrayexpress
2010-12-11 | E-GEOD-25706 | biostudies-arrayexpress
2014-01-16 | E-GEOD-50200 | biostudies-arrayexpress
2014-01-16 | E-GEOD-50198 | biostudies-arrayexpress
2014-12-03 | E-GEOD-63771 | biostudies-arrayexpress
2010-12-11 | GSE25706 | GEO